Abstract
In recent years, the biopharmaceutical industry has emerged as one of the most
important sectors in the Healthcare industry. Advances in life sciences have
resulted in the drug discovery process becoming more science-intensive, with
an increasing emphasis cross-company collaborations and the exchange of
information. However, growing commercial pressures and rising R&D costs have
prompted many biotech companies to seek financial support from global Big
Pharma corporations through licensing and collaborative R&D deals. Progressive
enhancements in integration have subsequently led to traditional pharma
companies becoming increasingly dependant upon the technology platforms and
approaches adopted by biotech companies. The Fastest Growing Biopharmaceutical
Companies: Growth strategies, comparative analysis and company profiles is a
new report published by Business Insights that examines the structure and
organization of the biopharmaceutical industry with a detailed analysis of the
fastest growing biopharmaceutical companies. This report provides a
comparative analysis of growth strategies and reviews the methods used to
improve operational efficiency in light of cost pressures, generic
competition, complex pricing, regulations, and globalization. This report also
explores the levels of interaction and integration between biopharma companies
and the wider pharma industry. Use key indicators to assess the performances
of the fastest growing biopharma companies, benchmark their most successful
strategies and understand major industrial issues with this new report.
View Cart
